Similarly, the frequency of CD11b+Gr1+ MDSCs in the liver of NAFLD mice was significantly higher than that of the control group, which may partly recruit to the NAFLD liver through the CCL2-CCR2 pathway and expanded through CSF stimulation [84]. The gene discussed is CCL2; the disease is metabolic dysfunction-associated steatotic liver disease.